PFG Investments LLC purchased a new stake in shares of BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 50,728 shares of the company’s stock, valued at approximately $750,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. AdvisorNet Financial Inc increased its holdings in shares of BlackRock Capital Allocation Term Trust by 53.8% in the third quarter. AdvisorNet Financial Inc now owns 2,995 shares of the company’s stock valued at $44,000 after purchasing an additional 1,048 shares during the last quarter. Joseph P. Lucia & Associates LLC boosted its holdings in shares of BlackRock Capital Allocation Term Trust by 4.6% during the 3rd quarter. Joseph P. Lucia & Associates LLC now owns 34,579 shares of the company’s stock worth $511,000 after buying an additional 1,513 shares during the period. Amplius Wealth Advisors LLC grew its stake in BlackRock Capital Allocation Term Trust by 5.4% in the 2nd quarter. Amplius Wealth Advisors LLC now owns 30,576 shares of the company’s stock valued at $463,000 after buying an additional 1,571 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in BlackRock Capital Allocation Term Trust by 341.7% in the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock valued at $31,000 after acquiring an additional 1,582 shares during the period. Finally, Red Tortoise LLC bought a new position in BlackRock Capital Allocation Term Trust in the 2nd quarter valued at about $33,000. 36.12% of the stock is owned by institutional investors.
BlackRock Capital Allocation Term Trust Stock Performance
Shares of BCAT stock opened at $14.67 on Tuesday. BlackRock Capital Allocation Term Trust has a 12-month low of $12.91 and a 12-month high of $15.91. The firm has a 50 day moving average price of $14.37 and a two-hundred day moving average price of $14.66.
BlackRock Capital Allocation Term Trust Announces Dividend
BlackRock Capital Allocation Term Trust Company Profile
BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.
BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.
Featured Stories
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCAT – Free Report).
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
